Cargando…
Real-world effectiveness and safety profile of teriflunomide in the management of multiple sclerosis in the Gulf Cooperation Council countries: An expert consensus narrative review
BACKGROUND: The prevalence of multiple sclerosis (MS) is increasing in Gulf Cooperation Council (GCC) countries. Multiple sclerosis contributes to significant burden on patients and caregivers. The pharmacological treatment in MS involves treating acute exacerbations and preventing relapses and disa...
Autores principales: | Alroughani, Raed, Inshasi, Jihad, Al Khawajah, Mona, Ahmed, Samar Farouk, Al Malik, Yaser, Alkhabouri, Jaber, Shatila, Ahmed, Aljarallah, Salman, Cupler, Edward J, Qureshi, Shireen Al, Thakre, Mona, Elhasin, Heba, Ezzat, Aly, Roushdy, Sherif |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8915209/ https://www.ncbi.nlm.nih.gov/pubmed/35284088 http://dx.doi.org/10.1177/20552173221077185 |
Ejemplares similares
-
Disease-Modifying Drugs and Family Planning in People with Multiple Sclerosis: A Consensus Narrative Review from the Gulf Region
por: Alroughani, Raed, et al.
Publicado: (2020) -
Expert Consensus and Narrative Review on the Management of Multiple Sclerosis in the Arabian Gulf in the COVID-19 Era: Focus on Disease-Modifying Therapies and Vaccination Against COVID-19
por: Inshasi, Jihad, et al.
Publicado: (2021) -
Multicentre Observational Study of Treatment Satisfaction with Cladribine Tablets in the Management of Relapsing Multiple Sclerosis in the Arabian Gulf: The CLUE Study
por: Inshasi, Jihad, et al.
Publicado: (2023) -
The use of alemtuzumab in patients with relapsing-remitting multiple
sclerosis: the Gulf perspective
por: Alroughani, Raed, et al.
Publicado: (2020) -
An Overview of High-Efficacy Drugs for Multiple Sclerosis: Gulf Region Expert Opinion
por: Alroughani, Raed, et al.
Publicado: (2019)